|
|
Volumn 111, Issue 23, 2005, Pages
|
|
Rate control is preferable to rhythm control in the majority of patients with atrial fibrillation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIODARONE;
ANTIARRHYTHMIC AGENT;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIGOXIN;
DILTIAZEM;
DISOPYRAMIDE;
DOFETILIDE;
FLECAINIDE;
PROCAINAMIDE;
PROPAFENONE;
QUINIDINE;
SOTALOL;
VERAPAMIL;
WARFARIN;
ANTICOAGULANT AGENT;
ANTICOAGULATION;
BRADYCARDIA;
CATHETER ABLATION;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG CONTRAINDICATION;
DRUG SAFETY;
HEART ATRIUM FIBRILLATION;
HEART DISEASE;
HEART PROARRHYTHMIA;
HEART RATE;
HEART RHYTHM;
HUMAN;
HYPERTHYROIDISM;
HYPOTHYROIDISM;
KIDNEY DISEASE;
LIVER TOXICITY;
LUNG FIBROSIS;
MEDICAL EDUCATION;
MEDICAL PRACTICE;
NOTE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RADIOFREQUENCY ABLATION;
SHOCK;
SINUS RHYTHM;
SUDDEN DEATH;
TORSADE DES POINTES;
TREATMENT OUTCOME;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
DISEASE MANAGEMENT;
HEART ARRHYTHMIA;
PATHOPHYSIOLOGY;
ANTI-ARRHYTHMIA AGENTS;
ANTICOAGULANTS;
ARRHYTHMIA;
ATRIAL FIBRILLATION;
CATHETER ABLATION;
CEREBROVASCULAR ACCIDENT;
DISEASE MANAGEMENT;
HEART RATE;
HUMANS;
TREATMENT OUTCOME;
|
|
EID: 20544432236
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.104.485565 Document Type: Note |
|
Times cited : (34)
|
|
References (0)
|
